Article Information
vol. 8 no. 4
Published By
Online ISSN
History
- Received May 12, 2022
- Accepted August 18, 2022
- Published online November 21, 2022.
Article Versions
- previous version (September 16, 2022 - 05:57).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- David A. Wohl1,2⇑,
- Aprille A. Espinueva3,
- Lauren Dau3,
- Chen-Yu Wang3,
- Alexandra Lachmann3,
- Rujuta A. Bam3,
- Aaditya Rawal4,
- Kerris Chappell-Smith5 and
- Juergen K. Rockstroh6,7
- 1Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 2School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 3Gilead Sciences Inc., Foster City, CA, USA
- 4Costello Medical, Boston, MA, USA
- 5Costello Medical, Cambridge, UK
- 6Department of Internal Medicine, University Hospital Bonn, Bonn, Germany
- 7German Centre for Infection Research, Partner Site Cologne-Bonn, Bonn, Germany
- Corresponding author: David A. Wohl (wohl{at}med.unc.edu)
Funding
Gilead Sciences
Article usage
Altmetrics
Vol 8 Issue 4
Table of Contents
COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines
